logo
Plus   Neg
Share
Email

Entertainment One Q1 Underlying EBITDA Declines; Revenue Down 7% - Quick Facts

Entertainment One Ltd (ETO.L) reported that its first-quarter Group underlying EBITDA declined 23 percent year-on-year driven by an increase in Group costs. An increase in underlying EBITDA of Music was offset by lower EBITDA in Film and TV. Group reported revenue was 7 percent lower than the prior period, impacted by lower Film, Television & Music. Family & Brands revenue was broadly stable compared to the prior period.

For the first-quarter, on a reported basis, loss before tax widened to 43.9 million pounds from a loss of 6.8 million pounds. Loss per share were 8.3 pence compared to a loss of 1.9 pence, previous year, reflecting the higher one-off charges. Underlying EBITDA declined to 13.4 million pounds from 17.3 million pounds. Adjusted loss per share was 0.3 pence compared to profit per share of 0.8 pence.

First-quarter revenue declined to 173.1 million pounds from 185.7 million pounds, prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT